Transcatheter Mitral Repair and Replacement Market Expected To Behold a CAGR Of 30.0% Through 2017-2023 | by LivaNova Plc, Abbott Laboratories, Biotronik Pvt Ltd, Edward Lifesciences etc Top Players

The Transcatheter Mitral Repair and Replacement Market is in its infancy because it is a new technology, and many healthcare professionals and individuals are unaware of the benefits associated with surgery. The percutaneous mitral valve reconstruction and replacement market has emerged as an effective treatment for symptomatic severe mitral regurgitation (MR) in patients who are thought to be untreatable or have a high operative risk for mitral valve surgery.

The Transcatheter Mitral Repair and Replacement Market is expected to reach $ 1,878 million (both repair and replacement valves) by 2023, with a CAGR of 30.0% from 2017 to 2023. Mechanical valve segments accounted for the largest share of the entire market in 2016.

The increase in the elderly population and the increase in mitral disease lead to market growth. In addition, introducing novel mitral valve combined with technological advancement is another factor driving market growth. The major limitations observed in this market are the high regulation costs of mitral valve surgery and the high risk associated with these procedures, as well as the strict regulation of crown judges. Moreover, increased health spending and emergence in developing countries will create opportunities for key market participants

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/4512

The report provides a comprehensive analysis of the key players operating in the global transcatheter mitral valve repair & replacement market such as
• LivaNova Plc
• Abbott Laboratories
• Biotronik Pvt Ltd
• Edward Lifesciences
• Medtronic Plc
• Neovasc Inc.
• NeoChord
• St. Jude Medical
• Direct Flow Medical Inc.
• Colibri Heart Valve LLC.

The other players in the value chain of the global transcatheter mitral valve repair and replacement market include Venus Medtech, HLT Medical, Transcatheter Technologies GmbH, MValve Technologies, Coramaze Technologies GmbH, and Mardil Medical.

Mitral valve Stenosis application is anticipated to maintain its dominance during the forecast period, owing to the high prevalence of mitral valve stenosis caused by the rheumatic fever, which is an infectious heart disease. This has led to the remarkable demand for the tanscatheter mitral valve repair & replacement devices.

Make an Enquiry before Buy @ https://www.alliedmarketresearch.com/purchase-enquiry/4512

Key Findings of the Transcatheter Mitral Valve Repair and Replacement Market
• The U.S. was the major shareholder in the North America transcatheter mitral valve repair & replacement market, and accounted for the highest share in 2016.
• Bioprosthetic tissue (biological) valves is expected to grow at the significant CAGR of 30.5% during 2017-2023.
• China occupied about one-fourth share of the total Asia-Pacific transcatheter mitral valve repair & replacement market in 2016. Whereas, India is expected to grow rapidly registering a CAGR of 32.9% during the forecast period.
• The mitral valve regurgitation segment is growing at a highest CAGR of 33.5% from 2017 to 2023.
• UK is anticipated to exhibit a highest CAGR during the forecast period.

In 2016, Asia-Pacific and LAMEA collectively accounted for about one-third share of the global transcatheter mitral valve repair & replacement market and is expected to continue this trend throughout the forecast period. Key factors driving the market include the prevalence of mitral valve diseases and deaths caused owing to this disease. Mitral valve diseases are sometimes inoperable and can be treated by performing mitral valve surgeries.

Access Full Summery @ https://www.alliedmarketresearch.com/transcatheter-mitral-valve-repair-and-replacement-market

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:

David Correa

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States

Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975

help@alliedmarketresearch.com

This release was published on openPR.